Neuroleptikoina

Neuroleptikoina is a Finnish term that translates to antipsychotics in English. Antipsychotics are a class of psychiatric medications primarily used to manage psychosis, including hallucinations and delusions. They are most commonly used to treat schizophrenia and bipolar disorder, but can also be used for other conditions such as severe depression or agitation.

These medications work by affecting neurotransmitters in the brain, particularly dopamine and serotonin. By blocking or altering the activity of these chemicals, antipsychotics can help to reduce the intensity of psychotic symptoms. They are available in various forms, including oral tablets, liquid solutions, and long-acting injections.

Antipsychotics are broadly categorized into two main groups: typical (first-generation) and atypical (second-generation) antipsychotics. Atypical antipsychotics are generally preferred due to a lower risk of certain side effects, though both types can have a range of adverse effects. These can include weight gain, drowsiness, movement disorders, and hormonal changes. The choice of antipsychotic and its dosage are tailored to the individual patient's needs and medical history. Treatment with neuroleptikoina is typically part of a comprehensive treatment plan that may also include psychotherapy and social support.